Abiopharma

Clinical trial NCT04876248: primary completion date: 2026-12-01 → 2026-10-21.

Clinical trial NCT04852601 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-05-31 3. enrollment: 41500 → 35403 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07365839 updates: 1. start date: 2026-07-01 → 2026-10-01 2. completion date: 2035-02-28 → 2035-05-28 3. primary completion date: 2035-02-28 → 2035-05-28

Clinical trial NCT05460767 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. completion date: 2024-12-31 → 2027-06-30 3. primary completion date: 2024-03-31 → 2026-12-31 4. enrollment: 260 → 504 participants 5. enrollment type: ESTIMATED → ACTUAL 6. allocation: NA → NON_RANDOMIZED

Clinical trial NCT07412262 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-15 → 2026-08-28

Clinical trial NCT05030428 updates: 1. completion date: 2027-10-13 → 2027-05-10 2. primary completion date: 2027-10-13 → 2027-05-10

Clinical trial NCT06672718: status: ACTIVE_NOT_RECRUITING → COMPLETED.

Clinical trial NCT05198245 updates: 1. completion date: 2028-04-17 → 2028-04-30 2. collaborators added: Carelon Research, Inc

Clinical trial NCT07772492: start date: 2026-08-30 → 2026-08-20.

Clinical trial NCT07212140: start date: 2026-06-01 → 2026-11-01.

Clinical trial NCT07594626 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2027-12-09 → 2026-08-21

Clinical trial NCT06053736: enrollment: 26 → 32 participants.

Clinical trial NCT06991556: enrollment: 165 → 166 participants.

Clinical trial NCT05756426: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT05663931: completion date: 2026-05-01 → 2026-11-01.